Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Clinical trial NCT07604571 · RECRUITING
Trial details
- NCT number
- NCT07604571
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-28
- Primary completion
- 2032-06-08
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.